Bio-Solutions Corp to begin the first production run of Type 2 Defense™ in eight weeks.

SAN ANTONIO, (PINKSHEETS: BISU) Bio-Solutions Corp is pleased to announce that the company has agreed to begin production of Type2 Defense™ in eight weeks with supplement producer NutriCap Labs of Farmingdale, New York.
 
March 7, 2013 - PRLog -- Type 2 Defense™ is an Antioxidant and glucose dietary supplement powder. This proprietary formula is packaged with 30 packets to a box. The product powder drink mix delivery system that may help support healthy glucose levels for type 2 diabetics and pre-diabetics.Type 2 Defense™ has been scheduled for Market entry in early 2013. "The company has been working on this project for a long time. We are now getting very close to completing the both the Type 2 Defense™ first production run, in addition to the finalization of the company and product websites. We are excited about our new product, which will be primarily sold and marketed online. The company's new product website www.type2defense.com is currently under construction and will be ready to take orders before the company's first production run is complete," stated president Bill Gallagher. In addition, the company has established a warehouse and expediting facility approximately one mile from the NutriCap Labs plant in Farmingdale, New York..

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions actual results to differ materially from those in the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.

Contact Investor & Public Relations

Bill Gallagher

President

Bio-Solutions Corp.

(210) 373-8104
End
Source: » Follow
Email:***@biosolutionscorp.com Email Verified
Tags:Health, Diabetes, Food
Industry:Health, Marketing
Location:United States
Subject:Projects
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share